Patients Co-developing companion diagnostics to connect patients with... Companion diagnostic (CDx) tests play a critical role in personalising care by identifying optimal targeted therapies for patients based on their cancer’s unique genetic profile.
Digital From signatures to success: How digital consent accelerates ... Informed consent is a foundational element of every clinical trial.
News US is planning $500m project on 'universal vaccines;' WSJ The US will spend $500m to develop universal vaccines against multiple virus variants, while planned changes to testing rules are raising concerns.
News AbbVie files fast-acting Botox successor in US AbbVie is hoping to extend its range of neurotoxin-based pharma and cosmetic products with a short-acting successor to its blockbuster Botox brand.
News There's good news for RSV jab firms at delayed ACIP meeting GSK and Pfizer could see a resurgence in sales of their RSV vaccines if new recommendations at a CDC expert meeting are confirmed by agency leaders.
Market Access Streamlining JCA response with GenAI The Joint Clinical Assessment (JCA) framework took effect on 12th January 2025, and its impact is top of mind among pharma innovators today.
News Lilly plans Q1 2027 filing for obesity triple retatrutide Armed with new pivotal trial results, Eli Lilly is preparing to file for approval of its triple-acting weight-loss therapy, retatrutide, next year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.